InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,426.40
(
0.12%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.89
(
0.12%
)
Bitcoin
64,933.49
(
-0.32%
)
Post# of 252254
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 128239

Tuesday, 10/11/2011 2:40:31 PM

Tuesday, October 11, 2011 2:40:31 PM

Post# of 252254
One case that comes to mind of generic-drug litigation of process patents is Pfizer vs. Ranbaxy's over two Lipitor patents #6,087,511 and #6,274,740 that expire in 2016.
Another case that was settled with several generics is Sepracor's Xopenex nebules which is protected by few method of use patents expiring until 2013 and one process patent #6,451,289 that expire in 2021.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up